Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market. Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk. Both stocks have skyrocketed thanks …